ES2078431T3 - Derivados de tetralina y cromano para el tratamiento de asma, artritis y enfermedades relacionadas. - Google Patents

Derivados de tetralina y cromano para el tratamiento de asma, artritis y enfermedades relacionadas.

Info

Publication number
ES2078431T3
ES2078431T3 ES91300660T ES91300660T ES2078431T3 ES 2078431 T3 ES2078431 T3 ES 2078431T3 ES 91300660 T ES91300660 T ES 91300660T ES 91300660 T ES91300660 T ES 91300660T ES 2078431 T3 ES2078431 T3 ES 2078431T3
Authority
ES
Spain
Prior art keywords
asthma
arthritis
treatment
related diseases
tetraline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91300660T
Other languages
English (en)
Inventor
James Frederick Eggler Jr
Lawrence Sherman Melvin Jr
Anthony Marfat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of ES2078431T3 publication Critical patent/ES2078431T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

SON COMPUESTOS DE FORMULA EN DONDE R ES UN GRUPO HETEROARILO OPCIONALMENTE SUSTITUIDO COMO EL 2-CROMANIL, 2-PIRIDIL O 5-FLUORO-2-BENZOTIAZOILO, X ES O, S O (CH SUB 2) SUB M R ELEVADO A 1 ES UN GRUPO FENIL O PIRIDIL OPCIONALMENTE SUSTITUIDO POR UNO O MAS DE UNO DE LOS GRUPOS (C SUB 1-C SUB 3)ALKILO, (C SUB 1-C SUB 3) ALKOXI, CARBOXI O [(C SUB 1-C SUB 3)ALKOXI] CARBONILO, N ES 0, 1, O 2 M ES 1 O 2 Y Y Y'' JUNTAS SON UN OXIGENO, Y SI SON SEPARADAS, Y ES UN HIDROGENO Y Y'' ES UN HIDROXI O UN GRUPO ACICLOXI HIDROLIZABLE "IN VIVO", Z ES CH SUB 2 NR SUB 2, O O S, Y R (AL CUADRADO) ES UN HIDROGENO O UN (C SUB 1-C SUB 3)ALKILO. ESTOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DEL ASMA, LA ARTRITIS Y LAS ENFERMEDADES RELACIONADAS CON MEDIACION DE LOS LEUCOTRIENOS.
ES91300660T 1990-02-07 1991-01-29 Derivados de tetralina y cromano para el tratamiento de asma, artritis y enfermedades relacionadas. Expired - Lifetime ES2078431T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1990/000692 WO1991012253A1 (en) 1990-02-07 1990-02-07 Tetralin and chroman derivatives useful in the treatment of asthma, arthritis, and related diseases

Publications (1)

Publication Number Publication Date
ES2078431T3 true ES2078431T3 (es) 1995-12-16

Family

ID=22220668

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91300660T Expired - Lifetime ES2078431T3 (es) 1990-02-07 1991-01-29 Derivados de tetralina y cromano para el tratamiento de asma, artritis y enfermedades relacionadas.

Country Status (12)

Country Link
EP (1) EP0441515B1 (es)
JP (1) JPH0737446B2 (es)
AT (1) ATE128706T1 (es)
CA (1) CA2035626A1 (es)
DE (1) DE69113487T2 (es)
DK (1) DK0441515T3 (es)
ES (1) ES2078431T3 (es)
FI (1) FI923546A0 (es)
GR (1) GR3018217T3 (es)
IE (1) IE68450B1 (es)
PT (1) PT96671B (es)
WO (1) WO1991012253A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9300312A (es) * 1992-01-23 1993-07-31 Pfizer Antagonistas benzopiranicos y relacionado de ltb.
AU5016793A (en) * 1992-08-20 1994-03-15 Cytomed, Inc Dual functional anti-inflammatory and immunosuppressive agents
KR100830252B1 (ko) 2000-11-06 2008-05-16 마츠시타 덴끼 산교 가부시키가이샤 소형 모터
JP3948016B2 (ja) 2002-06-27 2007-07-25 株式会社デンソー スロットル装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680404A (en) * 1983-01-13 1987-07-14 Pfizer Inc. Benzopyrans
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
US4661596A (en) * 1985-02-21 1987-04-28 American Home Products Corporation Quinolinyl (or pyridinyl) methoxy substituted naphthalene compounds as antiallergic agents
DK196688A (da) * 1987-04-28 1988-10-29 Fujisawa Pharmaceutical Co Bicykliske forbindelser og fremgangsmaade til fremstilling deraf
MX13485A (es) * 1987-10-19 1993-05-01 Pfizer Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos

Also Published As

Publication number Publication date
IE910385A1 (en) 1991-08-14
DK0441515T3 (da) 1996-02-05
EP0441515B1 (en) 1995-10-04
IE68450B1 (en) 1996-06-26
JPH0737446B2 (ja) 1995-04-26
FI923546A (fi) 1992-08-06
PT96671B (pt) 1998-07-31
PT96671A (pt) 1991-10-31
WO1991012253A1 (en) 1991-08-22
EP0441515A1 (en) 1991-08-14
DE69113487T2 (de) 1996-03-07
CA2035626A1 (en) 1991-08-08
DE69113487D1 (de) 1995-11-09
GR3018217T3 (en) 1996-02-29
FI923546A0 (fi) 1992-08-06
ATE128706T1 (de) 1995-10-15
JPH059174A (ja) 1993-01-19

Similar Documents

Publication Publication Date Title
ATE254594T1 (de) Verbindungen verwendbar als zwischenprodukte zur herstellung von piperidinderivate
DE68916699D1 (de) Benzopyridopiperidin, -piperidyliden und -piperazin-Verbindungen, Zusammensetzungen, Methoden zur Herstellung und Verwendung.
DE69705480D1 (de) Verwendung von Oestrogenagonisten und -antagonisten zur Herstellung eines Medikaments zur Behandlung von Atherosklerose, unabhängig von Lipidsenkung
HUT59394A (en) Process for producing piperazine derivatives and pharmaceutical compositions comprising same
GB0108318D0 (en) Organic compounds
DE69432542D1 (de) Tetraderivate, ihre Herstellung und Verwendung
ES2078431T3 (es) Derivados de tetralina y cromano para el tratamiento de asma, artritis y enfermedades relacionadas.
FI905191A0 (fi) Bensocykloalylaminopyridinaminer och motsvarande foereningar, foerfarande och mellanprodukter foer deras framstaellning och deras anvaendning som laekemedel.
DE69416540D1 (de) Heterocyclische Verbindungen und pharmazeutische Verwendung
MY120618A (en) Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives.
ATE275558T1 (de) 4-arylpiperidinderivate zur behandlung von pruritus
TR200102205T2 (tr) Anti-konvülsan türevlerinin bulimia nevruza tedavisinde kullanılmaları.
PL320912A1 (en) Novel derivatives of coumarin and method of obtaining them
FI913506A0 (fi) Foerfarande foer framstaellning av 6-(substituerat aminopropionyl)-derivat av forskolin.
ES2089159T3 (es) Nuevos derivados de acido ascorbico.
DE50001075D1 (de) 4-Alkanoyl-3-thiazoline und deren Verwendung als Riech- und Aromastoffe

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 441515

Country of ref document: ES